FAIR-TrueFISP imaging of cerebral perfusion in areas of high magnetic susceptibility differences at 1.5 and 3 Tesla

被引:34
作者
Boss, Andreas
Martirosian, Petros
Klose, Uwe
Naegele, Thomas
Claussen, Claus D.
Schick, Fritz
机构
[1] Univ Tubingen, Sect Expt Radiol, Dept Diagnost Radiol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Sect Expt Radiol, CNS, D-72076 Tubingen, Germany
[3] Univ Tubingen, Dept Neuroradiol, D-72076 Tubingen, Germany
关键词
arterial spin labeling; cerebral blood flow; perfusion imaging; FAIR; FAIR-TrueFISP;
D O I
10.1002/jmri.20893
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
Purpose: To estimate cerebral blood perfusion in areas of strong magnetic susceptibility changes with high spatial and temporal resolution using a flow-sensitive alternating inversion recovery (FAIR) arterial spin labeling (ASL) method. Materials and Methods: We implemented an ASL method that is capable of imaging perfusion in areas of high magnetic susceptibility changes by combining a FAIR spin preparation with a true fast imaging in steady precession (TrueFISP) data acquisition strategy. A TrueFISP readout sequence was applied especially in regions with magnetic field inhomogeneities and compared with corresponding FAIR measurements obtained with a standard echo-planar imaging (EPI) readout. Quantitative perfusion images were obtained at 1.5 Tesla (1.5T) from eight healthy volunteers (24-42 years old) and one patient (23 years old). FAIR-TrueFISP perfusion images were compared with FAIR echo-planar images. T1 maps, which are necessary for quantitative perfusion estimation, were obtained with inversion recovery (IR) TrueFISP and IR EPI. Additionally, high-resolution perfusion measurements were performed on four volunteers at 3T. Results: The two ASL perfusion imaging modalities yielded comparable diagnostic image quality in brain areas with low susceptibility differences at 1.5T. Cerebral perfusion of gray matter (GM) areas was 105.7 +/- 5.2 mL/100 g/mmute for FAIR-TrueFISP and 88.8 +/- 14.6 mL/100 g/minute for FAIR-EPI at 1.5T, and 70.4 7.1 mL/100 g/minute for FAIR-TrueFISP and 63.5 +/- 6.9 mL/100 g/minute for FAIR-EPI at 3.0T. Higher perfusion values at 1.5T were due to more pronounced partial-volume effects from fast moving spins at lower spatial resolution. The FAIR-TrueFISP sequence showed no significant distortions and markedly reduced signal void artifacts in areas of high susceptibility changes (e.g., near brain-bone transitions and close to metallic clips) compared to FAIR-EPI At 3T, highly resolved FAIR-TrueFISP perfusion images were acquired with an in-plane resolution of up to 1.3 mm. Conclusion: FAIR-TrueFISP allows for assessment of cerebral perfusion in areas of critically high susceptibility changes with conventional ASL methods.
引用
收藏
页码:924 / 931
页数:8
相关论文
共 32 条
[1]
Dynamic susceptibility contrast MRI of gliomas [J].
Aronen, HJ ;
Perkiö, J .
NEUROIMAGING CLINICS OF NORTH AMERICA, 2002, 12 (04) :501-+
[2]
PHARMACOKINETIC PARAMETERS IN CNS GD-DTPA ENHANCED MR IMAGING [J].
BRIX, G ;
SEMMLER, W ;
PORT, R ;
SCHAD, LR ;
LAYER, G ;
LORENZ, WJ .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1991, 15 (04) :621-628
[3]
Measuring cerebral blood flow using magnetic resonance imaging techniques [J].
Calamante, F ;
Thomas, DL ;
Pell, GS ;
Wiersma, J ;
Turner, R .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (07) :701-735
[4]
Cha Soonmee, 2004, Top Magn Reson Imaging, V15, P279, DOI 10.1097/00002142-200410000-00002
[5]
Diffusion- and perfusion-weighted MRI patterns in borderzone infarcts [J].
Chaves, CJ ;
Silver, B ;
Schlaug, G ;
Dashe, J ;
Caplan, LR ;
Warach, S .
STROKE, 2000, 31 (05) :1090-1096
[6]
THE LOSS OF SMALL OBJECTS IN VARIABLE TE IMAGING - IMPLICATIONS FOR FSE, RARE, AND EPI [J].
CONSTABLE, RT ;
GORE, JC .
MAGNETIC RESONANCE IN MEDICINE, 1992, 28 (01) :9-24
[7]
Crelier GR, 1999, MAGNET RESON MED, V41, P132, DOI 10.1002/(SICI)1522-2594(199901)41:1<132::AID-MRM18>3.0.CO
[8]
2-5
[9]
DEIMLING M, 1994, P 2 ANN M ISMRM SAN
[10]
Noninvasive MRI evaluation of cerebral blood flow in cerebrovascular disease [J].
Detre, JA ;
Alsop, DC ;
Vives, LR ;
Maccotta, L ;
Teener, JW ;
Raps, EC .
NEUROLOGY, 1998, 50 (03) :633-641